Summary
In 41 Type 1 (insulin-dependent) diabetic patients, islet cell antibodies, anti-insulin antibodies, and immune complexes measured by two different methods (the C1q solid phase assay and the conglutinin binding test) were studied at diagnosis, and the influence of treatment with insulins of different purity was investigated during the first year of treatment. Twenty subjects were treated with conventional insulins (group 1) while 21 were treated with monocomponent porcine insulins (group 2). The prevalence of islet cell antibodies significantly decreased during the 12-month study period in the 41 patients. From the first month anti-insulin antibodies were always significantly higher in group 1 than in group 2. At diagnosis the prevalence of both types of immune complexes in the 41 patients was higher than in normal subjects. The immune complexes measured by the C1q solid phase method showed a significant and progressive reduction during the follow-up period, whereas the immune complexes assayed by conglutinin showed no significant variation in the same period. The presence of C1q immune complexes was found to correlate with the occurrence of islet cell antibodies both at diagnosis and during the follow-up period. The presence of conglutinin immune complexes, on the other hand, tended to parallel the increase of anti-insulin antibody levels.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Lendrum R, Walker G, Gamble DR (1975) Islet-cell antibodies in juvenile diabetes mellitus of recent onset. Lancet 1: 880–882
Bottazzo GF, Pujol-Borrel R, Doniach D (1981) Humoral and cellular immunity in diabetes mellitus. Clin Immunol Allergy 1: 139–159
Lernmark A, Baekkeskov S (1981) Islet cell antibodies. Theoretical and practical implications. Diabetologia 21: 431–435
Berson SA, Yalow RS (1959) Quantitative aspects of the reaction between insulin and insulin antibody. J Clin Invest 38: 1996–2016
Andreani D, Iavicoli M, Tamburrano G, Menzinger G (1974) Comparative trials with monocomponent (MC) and monospecies (MS) pork insulins in the treatment of diabetes mellitus,. Influence on antibody levels, on insulin requirement and some complications. Horm Metab Res 6: 447–454
Andersen OO (1976) Anti-insulin antibodies and late diabetic complications. Acta Endocrinol (Kbh) 83: 329–333
Werner AV, Larsen HW (1969) Immunohistological studies of human diabetic and non diabetic eyes. I Fluorescent labeling of insulin and anti-insulin antibodies. Acta Ophthalmol (Kbh) 47: 937–945
Wehner H, Huber H, Kronemberg KH (1973) The glomerular basement membrane of the rabbit kidney on long term treatment with heterologous insulin preparations of different pituitary. Diabetologia 9: 255–265
Kurtz AB, Nabarro JDN (1980) Circulating insulin binding antibodies. Diabetologia 19: 329–334
Jayarao K, Page Faulk W, Karam H, Grodsky GM, Forsham PH (1974) Evidence in support of the concept of immune complexes disease in insulin treated diabetics. In: Bastenie PA, Gepts W (eds) Immunity and autoimmunity in diabetes mellitus. Excerpta Medica, Amsterdam, pp 255–263
Følling I (1976) Insulin anti-insulin complexes. Acta Endocrinol 83 (Suppl 205) 199–201
Irvine WJ, Di Mario U, Guy K, Feek CM, Gray RS, Duncan LJP (1978) Immune complexes in newly diagnosed insulin dependent (type I) diabetics. J Clin Lab Immunol 1: 183–186
Irvine WJ, Di Mario U, Guy K, Iavicoli M, Pozzilli P, Lumbroso B, Andreani D (1978) Immune complexes and diabetic microangiopathy. J Clin Lab Immunol 1: 187–191
Di Mario U, Iavicoli M, Andreani D (1980) Circulating immune complexes in diabetes. Diabetologia 19: 89–92
Di Mario U, Iavicoli M, Ventriglia L, Galfo C, Bellagamba C, Trionfera G, Cicconetti C, Andreani D (1979) Immune complexes, microangiopathy and metabolic control in diabetes. In: Waldhäusl WK (ed) Diabetes 1979, Excerpta Medica, Amsterdam, pp 379–382
Irvine WJ, Di Mario U, Guy K, Borsey DR (1980) Immune complexes in Type I diabetics with persistent islet cell antibodies. J. Clin Lab Immunol 4: 87–89
Iavicoli M, Guy K, Ventriglia L, Galfo C, Di Nichilo M, Di Mario U, Andreani D (1981) Correlazione tra gli immunocomplessi circolanti ed il trattamento insulinico nel diabete mellito. J Endocrinol Invest 4 (Suppl 1): 317–319
Christiansen AH (1970) A new method for determination of insulin binding immunoglobulins in insulin treated diabetic patients. Horm Metab Res 2: 186–190
Hay FC, Nineham LJ, Roitt IM (1976) Routine assay for the detection of immune complexes of known immunoglobulin class using solid phase C1q. Clin Exp Immunol 24: 396–400
Casali P, Bossus A, Carpentier NA, Lambert PH (1977) Solid phase enzyme immunoassay or radioimmunoassay for the detection of immune complexes based on their recognition by conglutinin-conglutinin-binding test. A comparative study with 125I-labelled C1q binding and Raji cell Ria test. Clin Exp Immunol 29: 342–354
Andreani D, Di Mario U, Galfo C, Ventriglia L, Iavicoli M (1982) Immune complexes in diabetes mellitus: evaluation by two different methods. Acta Endocrinol (Kbh) 99: 239–244
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Iavicoli, M., Ventriglia, L., Di Mario, U. et al. Aspects of humoral immunity in a prospective study of type I (insulin-dependent) diabetic subjects treated with insulins of different purity. Diabetologia 24, 26–29 (1983). https://doi.org/10.1007/BF00275943
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00275943